Dr. Anthony Joseph Paravati, MD

Dr. Paravati practices at Kettering Health Main Campus in Kettering, Ohio, part of Kettering Adventist Healthcare.

Dr. Paravati's NPI, 1902169956, was assigned on June 23, 2012. Dr. Paravati graduated from Geisel School Of Medicine At Dartmouth in 2012. Dr. Paravati holds Ohio license 35.130797.

Dr. Paravati's primary practice is Kettering Health Main Campus, at 3535 Southern Boulevard, Kettering, OH 45429 in Montgomery County. The practice phone is (937) 298-4331.

Dr. Paravati's primary practice is Kettering Health Main Campus in Kettering, Ohio, part of Kettering Adventist Healthcare. Dr. Paravati is also affiliated with Kettering Health Dayton. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Paravati to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paravati practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Paravati's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Paravati is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Paravati's licenses on file in 2 states: Ohio and California.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Paravati treats.

CMS data shows 2,154 Medicare services from Dr. Paravati across 18 procedure codes in 2024, for 212 Medicare patients. Medicare paid $125,957 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Paravati in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paravati's median patient age at 68, with 48% women.

In 2024, Dr. Paravati wrote 99 Medicare Part D claims for 58 patients. 85% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $510 in total drug cost. In 2022, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Paravati for performance year 2024, reported as part of a group. Dr. Paravati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paravati as offering telehealth.

Dmand AI links 15 papers to Dr. Paravati, published from 2011 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Radiosurgery, Medicare and Radiotherapy Dosage. Dr. Paravati has published most often in Int J Radiat Oncol Biol Phys. Dr. Paravati's most frequent co-authors are James Don Murphy, MD, Loren K. Mell, MD and Sunil Jeram Advani, MD.

CMS Open Payments shows 37 general payments to Dr. Paravati from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Elekta, Inc. paid the most, $15,376.

Dr. Paravati graduated from Geisel School Of Medicine At Dartmouth in 2012.

Dr. Paravati is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.